Matthew L Rizk

5PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Epidemiological modellingAnthropology of developmentMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 27, 2026
Reply to: "The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient".

|Apr 14, 2026
The Future of Clinical Translational Pharmacology.

Matthew L Rizk, Anuradha Ramamoorthy, Stephani L Stancil

|Jan 26, 2026
Imipenem/cilastatin/relebactam dosing regimen justification using exposure-efficacy analyses in participants with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia in the RESTORE-IMI 2 phase 3 study.

Munjal Patel, Garrett Nieddu, C Andrew DeRyke

|Apr 08, 2025
ASCPT 125th Anniversary: A Society Leadership Perspective.

Matthew L Rizk, Abigail Gorman, Sandra A G Visser

|Apr 09, 2024
Molnupiravir: Mechanism of action, clinical, and translational science.

Brian M Maas, Julie Strizki, Randy R Miller

Pageof 1

Frequent Collaborators

3 joint publications

Sandra A G Visser

1 joint publications

Brian M Maas

1 joint publications

Julie Strizki

1 joint publications

Matthew G Johnson